See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: June 25, 2004

Tinea Capitis (Ringworm of the Scalp) Schizophrenia and Schizoaffective Disorders COPD (Chronic Obstructive Pulmonary Disease)

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Tinea Capitis (Ringworm of the Scalp)

A research study of investigational medication for the treatment of Tinea Capitis (Ringworm of the Scalp). Children between the ages of 4 and 12 who have a clinical diagnosis of ringworm of the scalp may be eligible to participate. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat346.html.

-----

Schizophrenia and Schizoaffective Disorders

A research study to compare the effectiveness of a marketed drug to placebo in the treatment of schizophrenia, as an add-on therapy to antipsychotics. Volunteers who have been diagnosed with schizophrenia and have been taking clozapine monotherapy or other atypical antipsychotic for at least 3 months prior to the study may be eligible to participate. Research site located in San Diego, Calif.

More Information

Please see http://www.centerwatch.com/patient/studies/cat135.html.

-----

COPD (Chronic Obstructive Pulmonary Disease)

A research study of an investigational medication for the treatment of COPD (Chronic Obstructive Pulmonary Disease). Volunteers who have been diagnosed with COPD, are a current or past smoker, and are between the ages of 40 and 75 may be eligible to participate. Research site located in Dallas, Texas.

More Information

Please see http://www.centerwatch.com/patient/studies/cat44.html.

-----

Copyright 2004 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.